lactose has been researched along with tacrolimus in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Gibbs, AC | 1 |
| Arata, Y; Blach, M; Brock, J; Hirabayashi, J; Kasai, K; Walzel, H | 1 |
| Coalson, JJ; O'Donnell, KP; Peters, JI; Talbert, RL; Watts, AB; Williams, RO | 1 |
| Higaki, K; Ogawara, K; Sako, K; Tsunashima, D; Yamashita, K | 1 |
| Purohit, HS; Taylor, LS; Trasi, NS | 1 |
| Hakomori, T; Higaki, K; Ogawara, KI; Sako, K; Tsunashima, D; Yamashita, K | 1 |
| Brooks, EG; Coalson, JJ; Das, NA; DeArmond, DT; Johnson, SB; O'Donnell, KP; Peters, JI; Simmons, JD; Wang, Y | 1 |
| Dolocan, A; Koleng, JJ; Ma, X; Moon, C; Sahakijpijarn, S; Su, Y; Williams, RO | 1 |
1 review(s) available for lactose and tacrolimus
| Article | Year |
|---|---|
Elements and modulation of functional dynamics.
Topics: Drug Design; Drug Resistance; Entropy; Magnetic Resonance Spectroscopy; Molecular Dynamics Simulation; Mutation; Protein Conformation; Proteins; Structure-Activity Relationship; Thermodynamics | 2014 |
1 trial(s) available for lactose and tacrolimus
| Article | Year |
|---|---|
Development of extended-release solid dispersion granules of tacrolimus: evaluation of release mechanism and human oral bioavailability.
Topics: Administration, Oral; Adult; Area Under Curve; Biological Availability; Cellulose; Chemistry, Pharmaceutical; Cross-Over Studies; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Humans; Hypromellose Derivatives; Immunosuppressive Agents; Lactose; Male; Middle Aged; Solvents; Tacrolimus; Young Adult | 2017 |
7 other study(ies) available for lactose and tacrolimus
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Galectin-induced activation of the transcription factors NFAT and AP-1 in human Jurkat T-lymphocytes.
Topics: alpha-Fetoproteins; Asialoglycoproteins; Binding Sites; Calcium Signaling; Cell Membrane; Cyclosporine; Cytosol; DNA-Binding Proteins; Female; Fetuins; Galectin 1; Gene Expression Regulation; Genes, Reporter; Humans; Jurkat Cells; Lactose; Lymphocyte Activation; NFATC Transcription Factors; Nuclear Proteins; Oligonucleotide Probes; Pancreatitis-Associated Proteins; Recombinant Fusion Proteins; T-Lymphocytes; Tacrolimus; Transcription Factor AP-1; Transcription Factors | 2002 |
Preclinical evaluation of tacrolimus colloidal dispersion for inhalation.
Topics: Administration, Inhalation; Animals; Blood Cell Count; Clinical Chemistry Tests; Colloids; Drug Evaluation, Preclinical; Drug Stability; Female; Graft Rejection; Immunosuppressive Agents; Lactose; Lung; Lung Transplantation; Male; Nebulizers and Vaporizers; Powder Diffraction; Rats; Solubility; Tacrolimus; Transplantation, Homologous | 2011 |
Preparation of extended release solid dispersion formulations of tacrolimus using ethylcellulose and hydroxypropylmethylcellulose by solvent evaporation method.
Topics: Administration, Oral; Animals; Biological Availability; Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Hypromellose Derivatives; Lactose; Macaca fascicularis; Male; Solubility; Solvents; Tacrolimus; Water | 2016 |
Evaluation of the Crystallization Tendency of Commercially Available Amorphous Tacrolimus Formulations Exposed to Different Stress Conditions.
Topics: Chemistry, Pharmaceutical; Cold Temperature; Crystallization; Drug Stability; Excipients; Humidity; Immunosuppressive Agents; Lactose; Physical Phenomena; Polymers; Solubility; Tacrolimus; Water; X-Ray Diffraction | 2017 |
The efficacy of inhaled nanoparticle tacrolimus in preventing rejection in an orthotopic rat lung transplant model.
Topics: Administration, Inhalation; Allografts; Animals; Calcineurin Inhibitors; Cytokines; Disease Models, Animal; Drug Compounding; Graft Rejection; Immunosuppressive Agents; Injections, Intramuscular; Lactose; Lung Transplantation; Male; Nanoparticles; Rats, Inbred BN; Rats, Inbred Lew; Tacrolimus | 2017 |
Using thin film freezing to minimize excipients in inhalable tacrolimus dry powder formulations.
Topics: Administration, Inhalation; Aerosols; Calcineurin Inhibitors; Chemistry, Pharmaceutical; Drug Compounding; Drug Liberation; Drug Stability; Drug Storage; Excipients; Freezing; Humidity; Lactose; Powders; Tacrolimus; Technology, Pharmaceutical; Temperature | 2020 |